Clinical Trials Logo

Clinical Trial Summary

This is a multicenter, national, retrospective chart-review study that will be based on the collection of data from electronical or paper-based medical records with available data on female patients diagnosed with metastatic brest cancer . The main purpose of this study is to provide accurate, evidence based description on the incidence of progression of metastatic breast cancer and its clinical management.


Clinical Trial Description

Epidemiology and Therapeutic Management of Metastatic Breast Cancer in Romania: A retrospective cohort study ;


Study Design

Observational Model: Cohort, Time Perspective: Retrospective


Related Conditions & MeSH terms


NCT number NCT01711502
Study type Observational
Source AstraZeneca
Contact
Status Completed
Phase N/A
Start date January 2013
Completion date June 2013

See also
  Status Clinical Trial Phase
Completed NCT01554371 - Eribulin in Combination With Cyclophosphamide in Patients With Solid Tumor Malignancies Phase 1/Phase 2
Completed NCT01703754 - Adenoviral Vector Monotherapy or Combination With Chemotherapy in Subjects With Recurrent/Metastatic Breast Cancer. Phase 2
Completed NCT01644890 - A Phase III Study of NK105 in Patients With Breast Cancer Phase 3
Recruiting NCT01993498 - Chronic Toxicities Related to Treatment in Patients With Localized Cancer N/A